Skip to search formSkip to main content

VCH-759

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The present study reports on evaluation of anti-HCV activity and QSAR of certain arylidenethiazolidinone derivatives as potential… Expand
Is this relevant?
2010
2010
The current standard of chronic hepatitis C therapy is the combined use of pegylated IFN-alpha 2a (PegIFN-alpha) and rybavirin… Expand
Is this relevant?
2009
2009
BACKGROUND/AIMS VCH-759 is a non-nucleoside inhibitor of HCV RNA-dependent polymerase with sub-micromolar IC(50) values versus… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2008
2008
Background: VCH-759 is a novel orally bioavailable non-nucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase. In… Expand
Is this relevant?